Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Fate Therapeutics Inc. (FATE)

18.68   -0.31 (-1.63%) 08-20 14:19
Open: 18.81 Pre. Close: 18.99
High: 19.02 Low: 18.48
Volume: 245,657 Market Cap: 1221M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 19.358 - 19.432 19.432 - 19.518
Low: 18.114 - 18.191 18.191 - 18.28
Close: 18.842 - 18.97 18.97 - 19.117

Technical analysis

as of: 2019-08-20 1:58:16 PM
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 24.07     One year: 26.65
Support: Support1: 17.04    Support2: 14.18
Resistance: Resistance1: 20.61    Resistance2: 22.82
Pivot: 19.15
Moving Average: MA(5): 18.35     MA(20): 19.91
MA(100): 18.95     MA(250): 16.28
MACD: MACD(12,26): -0.70     Signal(9): -0.55
Stochastic oscillator: %K(14,3): 30.08     %D(3): 23.48
RSI: RSI(14): 43.73
52-week: High: 22.82  Low: 11.00  Change(%): 65.3
Average Vol(K): 3-Month: 76453  10-Days: 72612

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
FATE has closed above bottom band by 41.6%. Bollinger Bands are 29.9% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 07 Aug 2019 18:11:00 Z
Fate Therapeutics, Inc. (FATE) Q2 2019 Earnings Call Transcript

Wed, 07 Aug 2019 01:13:01 Z
Fate Therapeutics (FATE) Reports Q2 Loss, Tops Revenue Estimates

Mon, 29 Jul 2019 17:01:48 Z
Will Fate Therapeutics (FATE) Report Negative Q2 Earnings? What You Should Know

Fri, 26 Jul 2019 17:09:00 Z
First Week of September 20th Options Trading For Fate Therapeutics (FATE)

Mon, 08 Jul 2019 14:10:37 Z
Are Natural Killer Cells the Next Big Thing in Immunotherapy?

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 65.19
Shares Float (M) 52.94
% Held by Insiders 2.29
% Held by Institutions 96.71
Shares Short (K) 9080
Shares Short P. Month (K)

Stock Financials

EPS -1.220
EPS Est. Current Year -0.970
EPS Est. Next Year -0.940
EPS Est. Next Quarter -0.250
Forward EPS -1.060
Book Value (p.s.) 1.950
PEG Ratio
Profit Margin
Operating Margin -958.25
Return on Assets (ttm) -34.4
Return on Equity (ttm) -84.8
Qtrly Rev. Growth 174.3
Gross Profit (p.s.) -0.787
Sales Per Share
EBITDA (p.s.) -1.171
Qtrly Earnings Growth
Operating Cash Flow (M) -52.38
Levered Free Cash Flow (M) -34.49

Stock Valuations

P/E -15.36
P/E Growth Ratio -0.01
P/BV 9.61
P/S 9397389312.00
P/CF -23.32

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.